Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
20.99
-0.73 (-3.36%)
At close: Jun 12, 2025, 4:00 PM
21.00
+0.01 (0.05%)
After-hours: Jun 12, 2025, 4:55 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $640.84 million as of June 12, 2025. Its market cap has increased by 1.30% in one year.
Market Cap
640.84M
Enterprise Value
-161.36M
1-Year Change
1.30%
Ranking
Category
Stock Price
$20.99
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $640.84M, an increase of 309.48%. That is a compound annual growth rate of 17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 663.20M | 17.40% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |